Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2017 08:30 ET | Source: Delcath Systems, Inc.

Delcath Issues Letter to Shareholders

NEW YORK, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
September 19, 2017 08:30 ET | Source: Delcath Systems, Inc.

Data on Delcath’s CHEMOSAT System Presented at CIRSE Annual Meeting

NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
September 14, 2017 16:15 ET | Source: Delcath Systems, Inc.

Delcath Announces Accelerated Listing on OTCQB

NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
September 13, 2017 06:30 ET | Source: Delcath Systems, Inc.

Delcath Announces Relisting on OTCQB

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
September 01, 2017 10:10 ET | Source: Delcath Systems, Inc.

Delcath Issues Letter to Stockholders

NEW YORK, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq:DCTH) (the "Company"), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers,...
August 29, 2017 06:30 ET | Source: Delcath Systems, Inc.

Delcath Announces Medical University of Hannover in Germany Celebrates 100th CHEMOSAT Treatment

NEW YORK, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, congratulates...
August 28, 2017 06:30 ET | Source: Delcath Systems, Inc.

Delcath Announces Agreement for Extinguishment of Convertible Notes with Majority Holder

Agreement Contingent upon Shareholder Vote in Favor of the Proposed Reverse Stock Split Voting Deadline Extended to September 7, 2017 NEW YORK, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Delcath Systems,...
August 22, 2017 08:30 ET | Source: Delcath Systems, Inc.

Delcath Systems, Inc. Announces Extension of Expiration Date of its Consent Solicitation and Ability to Change Consent Once Voted

NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH) (the “Company”) announced today that the deadline for its current Consent Solicitation (the “Consent Solicitation”),...
June 05, 2017 17:15 ET | Source: Delcath Systems, Inc.

Delcath Systems, Inc. Announces Adjournment of Annual Meeting Meeting Scheduled to Reconvene on June 16

NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH) (the “Company”) announced today that its 2017 Annual Meeting of Stockholders (the “Annual Meeting”), scheduled for...
May 09, 2017 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces First Quarter 2017 Financial Results

NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...